AKESO Eyecare
Ophthalmic innovation platform for next-generation medical devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $2.9m | Series B | |
| Total Funding | 000k | ||
Akeso Eyecare is an ophthalmic technology company established in Beijing, China, in 2014, that operates as a Contract Development and Manufacturing Organization (CDMO). The company focuses on developing and producing advanced medical devices and digital solutions for the vision care industry. Akeso serves a global client base that includes partners in ophthalmology, optometry, consumer electronics, and smart hardware industries.
The company's business model is centered on providing B2B support and platform-based solutions. It leverages proprietary technologies to deliver its services, including the MetaRx™ nano-lithography platform for manufacturing high-precision lenses, AI-powered diagnostic tools, and XR (Extended Reality) display systems designed for visual health. Akeso generates revenue through these CDMO services and by providing its partners with end-to-end product development.
Key offerings include wearable myopia control devices, AI-based systems for detecting eye diseases, and advanced AR/VR vision platforms for applications like vision training. The company was founded by doctors and maintains a strong focus on research and development, with nearly 70% of its staff dedicated to R&D. Akeso has a diverse international team with a presence in China, India, Singapore, and Japan, enabling it to integrate insights from various markets.
Keywords: ophthalmic technology, vision care, medical devices, CDMO, contract development, nano-lithography, AI diagnostics, extended reality, XR optics, B2B eyecare, myopia control, wearable vision tech, AR/VR vision, eye-tracking, digital health, optometry solutions, ophthalmology innovation, smart hardware, consumer electronics optics